BeStock  
Stocks › Medical Devices › AXGN

AxoGen AXGN

US equityMarket cap rank #2355Medical Devices
$55.75 −$0.60 (-1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.10 +0.63%
Open$55.71
Prev close$56.35
Day range$55.03 – $56.91
Volume876.1K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$75.83M+26.2% YoY
Operating profit$955,000.00-50.1% YoY
Net profit$2.33M+229.7% YoY
Diluted EPS$0.04+300.0% YoY
Free cash flow$14.87M+995.0% YoY
Operating cash flow$16.54M

Revenue, last 8 quarters

$49.4MDec '24$48.6MMar '25$56.7MJun '25$60.1MSep '25$59.9MDec '25$61.5MMar '26$69.7MJun '26$75.8MSep '26

Net profit, last 8 quarters

$450.0KDec '24$-3.8MMar '25$579.0KJun '25$708.0KSep '25$-13.2MDec '25$-19.6MMar '26$-1.5MJun '26$2.3MSep '26

Diluted EPS by quarter

0.01Dec '24-0.08Mar '250.01Jun '250.01Sep '25-0.28Dec '25-0.38Mar '26-0.03Jun '260.04Sep '26

Free cash flow by quarter

$7.9MDec '24$-13.8MMar '25$6.6MJun '25$1.4MSep '25$1.1MDec '25$-1.4MMar '26$5.5MJun '26$14.9MSep '26

Annual revenue

$112.3MFY20$127.4MFY21$138.6MFY22$159.0MFY23$187.3MFY24$225.2MFY25

Profitability & balance sheet

Gross margin74.2%
Operating margin-5.2%
Net margin-12.0%
Return on equity-10.3%
Return on assets-8.3%
Return on invested capital-8.4%
Current ratio12.02
Liabilities / assets9.9%
Cash & investments$348.07M
Total debt$17.64M
Net cash (debt)$330.43M
Free cash flow / sales7.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $75.83M $69.73M $61.46M $225.21M $59.90M
Total Operating Revenue $75.83M $69.73M $61.46M $225.21M $59.90M
Cost of Revenue $19.10M $19.06M $15.27M $57.86M $15.50M
Gross Profit $56.73M $50.67M $46.19M $167.35M $44.41M
Operating Expense $55.78M $52.83M $49.02M $175.20M $54.18M
Selling and Admin Expenses $46.83M $44.24M $41.50M $142.32M $41.81M
-Selling & Marketing Expense $30.36M $30.83M $28.63M $97.74M $27.21M
-General & Admin Expense $16.47M $13.41M $12.87M $44.58M $14.59M
Research & Development $8.95M $8.59M $7.52M $32.89M $12.38M
Operating Profit $955,000.00 -$2.16M -$2.83M -$7.85M -$9.77M
Net Non-Operating Interest Income (Expense) -$1,000.00 -$1,000.00 -$694,000.00 -$7.70M -$1.72M
Non-Operating Interest Expense $1,000.00 $1,000.00 $694,000.00 $7.70M $1.72M
Other Income (Expense) $1.38M $641,000.00 -$16.06M -$152,000.00 -$1.67M
Gain on Sale of Security $1.43M $786,000.00 $768,000.00 -$319,000.00 -$1.67M
Special Income (Charges) $0.00 $0.00 -$16.85M – –
Other Non-Operating Income (Expenses) -$51,000.00 -$145,000.00 $23,000.00 $167,000.00 $0.00
Pretax Profit $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Net Profit $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Profit from Continuing Operations $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Net Income to Parent Company $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Net Income to Common Stockholders $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Basic EPS $0.04 -$0.03 -$0.38 -$0.34 -$0.28
Diluted EPS $0.04 -$0.03 -$0.38 -$0.34 -$0.28
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
-Less:Other Special Charges – – $16.85M – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $550.34M $304.86M $289.49M $221.69M $221.69M
Total Current Assets $438.09M $200.38M $184.71M $120.42M $120.42M
Cash and Cash Equivalents & Short-Term Investments $348.07M $111.41M $101.60M $41.53M $41.53M
-Cash and Cash Equivalents $328.89M $94.57M $82.65M $35.55M $35.55M
-Short Term Investments $19.18M $16.84M $18.95M $5.98M $5.98M
Receivables $34.01M $34.13M $28.31M $26.17M $26.17M
-Accounts Receivable $34.01M $34.13M $28.31M $26.17M $26.17M
Inventory $49.06M $47.31M $46.07M $42.37M $42.37M
Restricted Cash $2.00M $2.00M $2.00M $4.00M $4.00M
Other Current Assets $4.95M $5.53M $6.72M $6.35M $6.35M
Total Non-Current Assets $112.25M $104.49M $104.78M $101.27M $101.27M
Net PPE $95.34M $96.19M $97.32M $94.52M $94.52M
-Gross PPE $124.90M $124.18M $125.35M $120.95M $120.95M
-Accumulated Depreciation -$29.56M -$28.00M -$28.03M -$26.43M -$26.43M
Goodwill and Other Intangible Assets $7.91M $7.57M $7.27M $6.75M $6.75M
-Other Intangible Assets $7.91M $7.57M $7.27M $6.75M $6.75M
Other Non-Current Assets $9.00M $729,000.00 $192,000.00 – –
Total Liabilities $54.24M $48.61M $44.68M $92.84M $92.84M
Total Current Liabilities $36.46M $30.37M $26.01M $23.56M $23.56M
Short-Term Debt and Capital Lease Obligation $1.83M $1.98M $2.12M $2.37M $2.37M
-Current Capital Lease Obligation $1.83M $1.98M $2.12M $2.37M $2.37M
Total Non-Current Liabilities $17.78M $18.23M $18.67M $69.28M $69.28M
Long Term Debt and Capital Lease Obligation $17.64M $18.09M $18.53M $65.26M $65.26M
-Long Term Capital Lease Obligation $17.64M $18.09M $18.53M $16.87M $16.87M
Derivative Product Liabilities $0.00 $0.00 $0.00 $3.89M $3.89M
Other Non-Current Liabilities $141,000.00 $141,000.00 $140,000.00 $141,000.00 $141,000.00
Total Equity $496.10M $256.26M $244.81M $128.85M $128.85M
Stockholders' Equity $496.10M $256.26M $244.81M $128.85M $128.85M
Capital Stock $597,000.00 $537,000.00 $532,000.00 $472,000.00 $472,000.00
-Common Stock $597,000.00 $537,000.00 $532,000.00 $472,000.00 $472,000.00
Additional Paid-In Capital $821.24M $583.78M $570.82M $435.34M $435.34M
Retained Earnings -$325.73M -$328.06M -$326.55M -$306.96M -$306.96M
Payables – – – $2.89M $2.89M
-Accounts Payable – – – $2.89M $2.89M
Current Accrued Expenses – – – $1.67M $1.67M
-Long Term Debt – – – $48.39M $48.39M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $16.54M $7.22M $1.57M $812,000.00 $3.04M
Net cash flow from continuing operations $16.54M $7.22M $1.57M $812,000.00 $3.04M
Net Income from Continuing Operations $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
Gain/Loss from Continuing Operations -$62,000.00 -$136,000.00 $16.88M $1.16M $1.93M
Depreciation & Depletion & Amortization $2.14M $2.15M $2.13M $8.51M $2.97M
Other Non-Cash Items $0.00 $0.00 $68,000.00 $891,000.00 $225,000.00
Change in Working Capital $3.27M -$2.11M -$4.65M -$24.61M -$5.63M
-Change in Receivables $62,000.00 -$5.88M -$2.02M -$2.46M $4.56M
-Change in Inventory -$1.75M -$1.24M -$3.70M -$9.19M -$1.79M
-Change in Prepaid Assets $572,000.00 $1.20M -$368,000.00 -$3.91M -$3.29M
-Change in Payables and Accrued Expense $6.24M $4.92M $2.20M -$7.16M -$4.17M
-Change in Other Current Assets -$1.26M -$537,000.00 -$192,000.00 – –
-Change in Other Current Liabilities -$594,000.00 -$570,000.00 -$560,000.00 -$1.89M -$946,000.00
Net cash flow from investing -$10.93M $500,000.00 -$15.96M -$5.32M $4.04M
Net Cash Flow from Continuing Investing Activities -$10.93M $500,000.00 -$15.96M -$5.32M $4.04M
Net PPE Purchase and Sale -$1.39M -$893,000.00 -$2.79M -$3.75M -$1.25M
Net Intangibles Purchase and Sale -$274,000.00 -$857,000.00 -$175,000.00 -$1.85M -$711,000.00
Net Investment Purchase and Sale -$9.27M $2.25M -$13.00M $277,000.00 $6.00M
Financing Cash Flow $228.71M $4.20M $59.51M $10.50M $4.57M
Net Cash Flow from Continuing Financing Activities $228.71M $4.20M $59.51M $10.50M $4.57M
Net Issuance Payments Of Debt -$5,000.00 -$2,000.00 -$48.59M -$32,000.00 -$21,000.00
Net Common Stock Issuance $225.58M $0.00 $134.04M – –
Proceeds from Stock Option Exercised $3.86M $4.70M $4.23M $10.53M $4.59M
Net Other Financing Charges -$723,000.00 -$497,000.00 -$30.17M – –
Ending Cash Balance $330.89M $96.57M $84.65M $39.55M $39.55M
Net Change in Cash $234.32M $11.92M $45.11M $5.99M $11.65M
Beginning Cash Balance $96.57M $84.65M $39.55M $33.55M $27.90M
Free Cash Flow $14.87M $5.47M -$1.40M -$4.78M $1.08M

Discussion

No comments yet — be the first to weigh in on AXGN.

Sign in to join the discussion.

Scroll to Top